• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示群体蛋白质组学中的暗物质:与认知和衰老相关的单氨基酸多态性全分析

Uncovering dark mass in population proteomics: Pan-analysis of single amino acid polymorphism relevant to cognition and aging.

作者信息

Gao Xiaojing, Yin Yuanyuan, Chen Yiqian, Lu Ling, Zhao Jian, Lin Xu, Wu Jiarui, Li Qingrun, Zeng Rong

机构信息

Shanghai Clinical Research and Trial Center, ShanghaiTech University, Shanghai 201210, China; Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China; School of Life Sciences and Technology, ShanghaiTech University, Shanghai 201210, China.

Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.

出版信息

Cell Genom. 2025 Feb 12;5(2):100763. doi: 10.1016/j.xgen.2025.100763. Epub 2025 Jan 30.

DOI:10.1016/j.xgen.2025.100763
PMID:39889701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11872527/
Abstract

Human proteome data across populations have been analyzed extensively to reveal protein quantitative associations with physiological or pathological states, while the single amino acid polymorphism (SAP) has been rarely investigated. In this work, we introduce a pan-SAP workflow that relies on pan-database searching independent of individual genome sequencing. Using ten cohorts comprising 2,004 individuals related to cognition disorder and aging, we quantify the SAP sites in key proteins, such as apolipoprotein E (APOE) in plasma and cerebrospinal fluid at the proteome level. Specifically, the quantification of heterozygous APOE-C112R, including its abundance and ratio, provides insights into the dosage effect and relationship with cognition disorder, which cannot be interpreted at the genomic level. Furthermore, our approach could precisely track age-related changes in APOE-C112R levels. Taken together, this pan-SAP workflow uncovered existing but hidden SAPs in multi-populations, connecting SAP quantification to disease progression and paving the way for broader proteomic investigations in complex diseases.

摘要

为揭示蛋白质与生理或病理状态的定量关联,人们已对不同人群的人类蛋白质组数据进行了广泛分析,而单氨基酸多态性(SAP)却鲜有研究。在这项工作中,我们引入了一种泛SAP工作流程,该流程依赖于独立于个体基因组测序的泛数据库搜索。我们使用了十个队列,共2004名与认知障碍和衰老相关的个体,在蛋白质组水平上对关键蛋白质中的SAP位点进行定量,比如血浆和脑脊液中的载脂蛋白E(APOE)。具体而言,对杂合APOE-C112R的定量,包括其丰度和比例,为剂量效应以及与认知障碍的关系提供了见解,而这在基因组水平上无法得到解释。此外,我们的方法能够精确追踪APOE-C112R水平与年龄相关的变化。综上所述,这种泛SAP工作流程揭示了多人群中存在但隐藏的SAP,将SAP定量与疾病进展联系起来,为复杂疾病的更广泛蛋白质组学研究铺平了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/dd08b7228668/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/827a3b2fd6b8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/4916df516d22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/a86540d22ff1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/9783c0fcbe99/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/21b125e957f9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/dd08b7228668/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/827a3b2fd6b8/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/4916df516d22/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/a86540d22ff1/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/9783c0fcbe99/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/21b125e957f9/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/adf2/11872527/dd08b7228668/gr5.jpg

相似文献

1
Uncovering dark mass in population proteomics: Pan-analysis of single amino acid polymorphism relevant to cognition and aging.揭示群体蛋白质组学中的暗物质:与认知和衰老相关的单氨基酸多态性全分析
Cell Genom. 2025 Feb 12;5(2):100763. doi: 10.1016/j.xgen.2025.100763. Epub 2025 Jan 30.
2
Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.阿尔茨海默病患者和对照者脑脊液和血浆中的总载脂蛋白 E 水平及特定同工型组成。
Acta Neuropathol. 2014 May;127(5):633-43. doi: 10.1007/s00401-014-1266-2. Epub 2014 Mar 15.
3
Quantitative detection of single amino acid polymorphisms by targeted proteomics.通过靶向蛋白质组学定量检测单氨基酸多态性。
J Mol Cell Biol. 2011 Oct;3(5):309-15. doi: 10.1093/jmcb/mjr024.
4
Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.血浆 ApoE4 水平低于 ApoE2 和 ApoE3 水平,且与阿尔茨海默病淀粉样蛋白-β 淀粉样变性的生物标志物血浆 Aβ40/42 比值无关。
J Alzheimers Dis. 2023;93(1):333-348. doi: 10.3233/JAD-220996.
5
APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.与血浆相比,APOE ε3/ε4杂合子脑脊液中载脂蛋白E4的比例升高,这与阿尔茨海默病的诊断无关。
Exp Neurol. 2003 Sep;183(1):249-53. doi: 10.1016/s0014-4886(03)00088-8.
6
Investigating Effects of Plasma Apolipoprotein E on Ischemic Heart Disease Using Mendelian Randomization Study.采用孟德尔随机化研究探讨血浆载脂蛋白 E 对缺血性心脏病的影响。
Nutrients. 2021 Jun 28;13(7):2215. doi: 10.3390/nu13072215.
7
APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.载脂蛋白 E 基因型依赖性阿尔茨海默病和年龄匹配非痴呆脑脑血管分子异常。
Mol Brain. 2021 Jul 8;14(1):110. doi: 10.1186/s13041-021-00803-9.
8
The effects of an APOE promoter polymorphism on human cortical morphology during nondemented aging.一种载脂蛋白E(APOE)启动子多态性对非痴呆性衰老过程中人类皮质形态的影响。
J Neurosci. 2015 Jan 28;35(4):1423-31. doi: 10.1523/JNEUROSCI.1946-14.2015.
9
ApoE and Neurodegenerative Diseases in Aging.载脂蛋白 E 与衰老相关神经退行性疾病
Adv Exp Med Biol. 2018;1086:77-92. doi: 10.1007/978-981-13-1117-8_5.
10
Plasma apolipoproteins and physical and cognitive health in very old individuals.高龄个体的血浆载脂蛋白与身体和认知健康
Neurobiol Aging. 2017 Jul;55:49-60. doi: 10.1016/j.neurobiolaging.2017.02.017. Epub 2017 Mar 1.

引用本文的文献

1
Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration.能量代谢与脑衰老:延缓神经元变性的策略
Cell Mol Neurobiol. 2025 Apr 21;45(1):38. doi: 10.1007/s10571-025-01555-z.

本文引用的文献

1
Proteomic analysis of Alzheimer's disease cerebrospinal fluid reveals alterations associated with ε4 and atomoxetine treatment.阿尔茨海默病脑脊液蛋白质组学分析显示与 ε4 和托莫西汀治疗相关的改变。
Sci Transl Med. 2024 Jun 26;16(753):eadn3504. doi: 10.1126/scitranslmed.adn3504.
2
Multifaceted roles of APOE in Alzheimer disease.载脂蛋白E在阿尔茨海默病中的多方面作用。
Nat Rev Neurol. 2024 Aug;20(8):457-474. doi: 10.1038/s41582-024-00988-2. Epub 2024 Jun 21.
3
Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease.
可接受的淀粉样蛋白病理血生物标志物检测性能——来自全球阿尔茨海默病首席执行官倡议的建议。
Nat Rev Neurol. 2024 Jul;20(7):426-439. doi: 10.1038/s41582-024-00977-5. Epub 2024 Jun 12.
4
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease.载脂蛋白 E4 纯合子代表一种独特的阿尔茨海默病遗传形式。
Nat Med. 2024 May;30(5):1284-1291. doi: 10.1038/s41591-024-02931-w. Epub 2024 May 6.
5
Disease staging of Alzheimer's disease using a CSF-based biomarker model.采用基于脑脊液生物标志物模型对阿尔茨海默病进行疾病分期。
Nat Aging. 2024 May;4(5):694-708. doi: 10.1038/s43587-024-00599-y. Epub 2024 Mar 21.
6
Nanoparticle enrichment mass-spectrometry proteomics identifies protein-altering variants for precise pQTL mapping.纳米颗粒富集质谱蛋白质组学鉴定改变蛋白质的变异体,用于精确的 pQTL 映射。
Nat Commun. 2024 Feb 2;15(1):989. doi: 10.1038/s41467-024-45233-y.
7
Alzheimer's disease early diagnostic and staging biomarkers revealed by large-scale cerebrospinal fluid and serum proteomic profiling.通过大规模脑脊液和血清蛋白质组分析揭示的阿尔茨海默病早期诊断和分期生物标志物
Innovation (Camb). 2024 Jan 2;5(1):100544. doi: 10.1016/j.xinn.2023.100544. eCollection 2024 Jan 8.
8
Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease.非裔美国人和白种人脑脊液的定量蛋白质组学研究揭示了阿尔茨海默病的共同和差异变化。
Mol Neurodegener. 2023 Jul 19;18(1):48. doi: 10.1186/s13024-023-00638-z.
9
CSF proteome profiling across the Alzheimer's disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels.在阿尔茨海默病谱中进行脑脊液蛋白质组谱分析反映了疾病的多因素性质,并确定了特定的生物标志物组合。
Nat Aging. 2022 Nov;2(11):1040-1053. doi: 10.1038/s43587-022-00300-1. Epub 2022 Nov 10.
10
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.基于血浆生物标志物组合对轻度认知障碍认知能力下降和痴呆的个体化预后评估。
Nat Aging. 2021 Jan;1(1):114-123. doi: 10.1038/s43587-020-00003-5. Epub 2020 Nov 30.